University of Crete (UOC)
Μηχανισμοί κυτταρικού θανάτου των νευρώνων του εγκεφάλου στη νόσο του Alzheimer
Abstract
dc:descriptionEpidermal growth factor receptor (EGFR) plays pivotal roles in cell proliferation, differentiation, and tissue development, while EGFs protect neurons from toxic insults by binding EGFR and stimulating survival signaling. Furthermore, recent evidence implicates this receptor in neurometabolic disorders like Alzheimer disease (AD) and aging. This study was aimed at elucidating the mechanisms of cortical neuronal cell death in AD and the role of Presenilin 1 (PS1) in neuroprotection. PS1 mutations are responsible for the majority of the identified cases of patients with Familial Alzheimer’s Disease (FAD). In this study, it is shown for the first time that absence of presenilin 1 (PS1) results in dramatic decrease (>95%) of neuronal EGFR and that PS1-null (PS1(-/-)) brains have reduced amounts (~60%) of this receptor. PS1(-/-) cortical neurons contain little EGFR and show no epidermal growth factor-induced survival signaling or protection against excitotoxicity, but exogenous EGFR rescues both functions even in absence of PS1. EGFR mRNA is greatly reduced (>95%) in PS1(-/-) neurons, and PS1(-/-) brains contain decreased amounts of this mRNA, although PS1 affects the stability of neither EGFR nor its mRNA. Exogenous PS1 increases neuronal EGFR mRNA and reinstates EGF-induced neuroprotection against glutamate excitotoxicity, while down-regulation of PS1 decreases this mRNA and abolishes EGF-induced neuroprotection. These effects are neuron specific, as PS1 affects the EGFR of neither glial nor fibroblast cells. In addition, PS1 controls EGFR through novel mechanisms shared with neither γ-secretase nor PS2. Our data reveal that PS1 functions as a positive transcriptional regulator of neuronal EGFR controlling its expression in a cell-specific manner. Severe downregulation of EGFR may contribute to developmental abnormalities and lethal phenotype found in PS1, but not PS2, null mice. Furthermore, PS1 may affect neuroprotection and Alzheimer disease by controlling survival signaling of neuronal EGFR.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Voloudakis, Georgios
- Βολουδάκης, Γεώργιος
Subjects
dc:subject × 14- Νόσος του Alzheimer
- Νευρωνικός κυτταρικός θάνατος
- Νευροπροστασία
- Πρεσενιλίνη 1
- Υποδοχέας Επιδερμικού Αναπτυξιακού Παράγοντα
- Alzheimer's disease
- Νeuronal cell death
- Neuroprotection
- Presenilin 1
- EPIDERMAL GROWTH FACTOR RECEPTOR (EGF-R)
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
dc:rights- Statement dc:rights
-
- BY_NC
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36326